Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 26:20:1355-1366.
doi: 10.2147/NDT.S456272. eCollection 2024.

Prevalence of Generalized Anxiety Disorder in Japan: A General Population Survey

Satoshi Matsuyama  1 , Tempei Otsubo  2 , Keisuke Nomoto  1 , Shingo Higa  1 , Osamu Takashio  3
Affiliations

Prevalence of Generalized Anxiety Disorder in Japan: A General Population Survey

Satoshi Matsuyama et al. Neuropsychiatr Dis Treat. .

Abstract

Purpose: Generalized anxiety disorder (GAD) is among the most prevalent and highly disabling mental health conditions that negatively impacts patient's quality of life (QOL) and disrupts activities of daily living. However, the recognition of GAD is difficult due to substantial overlap with other mental disorders. The purpose of this study was to estimate the prevalence of GAD, assess QOL of probable GAD patients in Japan, and gain insights on the status of visiting medical institutions as well as their recognition/awareness of the disorder.

Patients and methods: We conducted a web-based cross-sectional survey of 20,009 participants using a questionnaire with approximately 30 single/multiple choice or open-ended questions in Japanese.

Results: Overall prevalence of GAD based on Generalized Anxiety Disorder 7-item (GAD-7) cutoff score of ≥10 and questionnaires developed with reference to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria was 7.6% (n=1530) and 6.0% (n=1197), respectively. The degree of coincidence between GAD diagnosis by DSM-5 criteria and GAD-7 scores was moderate (Cohen's Kappa=0.47, p<0.01). Younger people reported a substantially higher prevalence of GAD compared to older. QOL scores assessed using EuroQol 5 dimensions 5-level and EuroQol Visual Analog Scale were substantially lower in probable GAD patients than those with GAD-7<10. Anxiety/depression and pain/discomfort were the most prevalent issues and depression was the most reported comorbidity for the probable GAD patients. Probable GAD patients "currently visiting medical institutions" for anxiety or other mental issues were 27.6% (422/1530); a majority had seen specialists. Most of the probable GAD patients had never heard of the disease.

Conclusion: We found higher prevalence of GAD and lower QOL of probable GAD patients in Japan. There is a need for creating awareness about GAD among the general population and developing clinical guidelines on GAD in Japan so that physicians can educate their patients.

Keywords: GAD-7; Japan; generalized anxiety disorder; prevalence; quality of life.

PubMed Disclaimer

Conflict of interest statement

Satoshi Matsuyama, Keisuke Nomoto, and Shingo Higa are full-time employees of Viatris Pharmaceuticals Japan Inc. Tempei Otsubo has received lecture fees from Viatris Pharmaceuticals Japan Inc.; Takeda Pharmaceutical Co., Ltd.; Otsuka Pharmaceutical; Sumitomo Pharma Co., Ltd.; YoshitomiYakuhin; Mochida; Meiji Seika Pharma Co., Ltd.; Kyowa Pharmaceutical; Lundbeck Japan; and IQVIA. Osamu Takashio reported honoraria for lectures from Viatris Pharmaceuticals Japan Inc.; Meiji Seika Pharma Co., Ltd.; Takeda Pharmaceutical Co., Ltd.; Sumitomo Pharma Co., Ltd.; and Otsuka Pharmaceutical. The authors report no other conflicts of interest in this work.

Figures

Figure 1
Figure 1
History of mental disorders among probable GAD patients (n=1530).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. National Institute of Mental Health. Transforming the understanding and treatment of mental illnesses; 2023. Available from: https://www.nimh.nih.gov/health/statistics/generalized-anxiety-disorder#.... Accessed July 7, 2023.
    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5™). 5th ed. Washington, DC: American Psychiatric Association; 2013.
    1. Barrera TL, Norton PJ. Quality of life impairment in generalized anxiety disorder, social phobia, and panic disorder. J Anxiety Disord. 2009;23(8):1086–1090. doi:10.1016/j.janxdis.2009.07.011 - DOI - PMC - PubMed
    1. Takebayashi Y, Tanaka K, Sugiura Y, Sugiura T. Well-being and generalized anxiety in Japanese undergraduates: a prospective cohort study. J Happiness Stud. 2018;19:917–937. doi:10.1007/s10902-017-9852-3 - DOI
    1. Ruscio AM, Hallion LS, Lim CCW, et al. Cross-sectional comparison of the epidemiology of DSM-5 generalized anxiety disorder across the globe. JAMA Psychiatry. 2017;74(5):465–475. doi:10.1001/jamapsychiatry.2017.0056 - DOI - PMC - PubMed